Compassionate use of medicinal products in Europe: current status and perspectives-Reference-Cited by-同舟云学术

Compassionate use of medicinal products in Europe: current status and perspectives

Published:2011-03-01 Issue:3 Volume:89 Page:163-163
ISSN:0042-9686
Container-title:Bulletin of the World Health Organization
language:en
Short-container-title:Bull. World Health Organ.

Author:

Rahbari Mussa¹,Rahbari Nuh N²

Affiliation:

1. aFaculty of Law, Heinrich-Heine-University of Düsseldorf, Universitätsstrasse 1, 40225, Düsseldorf, Germany.

2. bDepartment of General, Visceral and Transplant Surgery, University of Heidelberg, Heidelberg, Germany.

Publisher

WHO Press

Subject

Public Health, Environmental and Occupational Health

Reference8 articles.

1. Regulation (EC) no. 726/2004 of the European Parliament and of the Council (OJ L 136, 30.4.2004). Available from: http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=CONSLEG:2004R0726:20090706:EN:PDF [accessed 20 January 2011].

2. Guideline on compassionate use of medicinal products, pursuant to Article 83 of Regulation (EC) no. 726/2004 (doc ref: EMEA/27170/2006). London: European Medicines Agency; 2007. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Regulatory_and_ procedural_guideline/2009/10/WC500004075.pdf [accessed 20 January 2011].

3. Compassionate use. London: European Medicines Agency; 2010. Available from: http://www.ema.europa.eu/ema/index.jsp?curl=pages/regulation/general/general_content_000293.jsp [accessed 20 January 2011].

4. Conditions of use, conditions for distribution and patients targeted and conditions for safety monitoring addressed to member states for Tamiflu IV available for compassionate use. London: European Medicines Agency; 2010. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2010/01/WC500069899.pdf [accessed 20 January 2011].

5. Summary on compassionate use for Tamiflu IV. London: European Medicines Agency; 2010. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Other/2010/05/WC500090250.pdf [accessed 20 January 2011].

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Qualitative Interview Study on Expanded Access Clinical Trials for Compassionate Use in Japan;Patient Preference and Adherence;2024-07

2. COVID-19 off-label uses of medicines: the role of civil liability and regulation;The Geneva Papers on Risk and Insurance - Issues and Practice;2023-05-19

3. Characteristics of the Compassionate Use Program in Japan: An Analysis of Expanded Access Clinical Trials from 2016 to 2021;Clinical Pharmacology & Therapeutics;2022-06-07

4. ¹⁷⁷ Lu‐PSMA radioligand therapy effectiveness in metastatic castration‐resistant prostate cancer: An updated systematic review and meta‐analysis;The Prostate;2022-03-14

5. Compassionate Use of GC5131 (Hyperimmunoglobulin) Therapy in Critically Ill Patients Diagnosed with COVID-19: A Case Series and Review of Literature;Viruses;2021-09-14